Medical News

RSS

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes -- all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Novel and more effective way of testing which gene mutations cause cancer

Often cancer research goes like this: study cancerous cells in a lab dish, find mutations that appear in many of the samples, develop drugs to target proteins made by the mutated genes, and voila, new chemotherapy drugs are born. Or at least that's the hope.

12 Jun 2005

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Type 2 diabetes may be significantly delayed or prevented through medication that takes the load off of the body's delicate insulin-producing cells, according to a study released today by researchers at the Keck School of Medicine of the University of Southern California.

12 Jun 2005

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

The good news is that there are nearly two million breast cancer survivors in the United States , and survival rates continue to increase for patients with this disease. But the flip side is that survival can present its own set of little-known complications.

12 Jun 2005

Researchers discover how microRNA are involved in the development of heart muscle

Researchers at UT Southwestern Medical Center have discovered how a small molecule of RNA called microRNA - a chemical cousin of DNA - helps fine tune the production of a key protein involved in the early development of heart muscle.

12 Jun 2005

Bio-engineered skin provides clues to melanoma development

When it comes to the deadly skin cancer melanoma, studying functional tissue rather than cell lines may better provide insight into the disease's development, according to new research from a Howard Hughes Medical Institute predoctoral fellow at Stanford University School of Medicine.

12 Jun 2005

Genetic variations predispose Mexican Americans to insulin resistance

Although numerous studies have shown that low-grade inflammation is linked to heart disease and diabetes, more recent studies have shown that inflammation plays a role in insulin resistance, a syndrome that leads to diabetes and heart disease and affects about one in four adults in the United States.

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Dendritic cell vaccination can dramatically speed up the immunization process

Parents often wonder why it takes a year or more and multiple shots to fully immunize their children against diseases like diphtheria and pertussis.

12 Jun 2005

Venom of marine cone snails may provide an improved treatment for neuropathic pain associated with diabetes

A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.

12 Jun 2005

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

Researchers in the UK are saying that some of the most commonly used painkillers are more likely to cause heart attacks than Vioxx, the arthritis drug withdrawn from the market last year after it was linked to heart disease.

12 Jun 2005

West Nile virus vaccine may be ready by the end of the year

A Dutch biotechnology manufacturer says it has identified a human antibody which has proven effective against West Nile virus in animal studies.

12 Jun 2005

FDA approves whooping cough vaccine for adults

The U.S. Food and Drug Administration (FDA) has given drug company Sanofi-Aventis approval to sell Adacel, a vaccine against whooping cough for people ages 11 to 64.

12 Jun 2005

Mad cow disease found in animal in the U.S.

In disturbing news this week, Agriculture Secretary Mike Johanns said a U.S. animal has tested positive for mad cow disease.

12 Jun 2005

No need to rush to take epilepsy drugs

A new study from the UK says that it is not neccessary to rush to put people on drugs if they have only infrequent seizures.

12 Jun 2005

Crystal Meth Summit in Canada wants drug re-classified

Crystal meth, a powerful addictive drug has now become such a problem in Canada that law enforcement officials met in Regina last week for a Crystal Meth Summit.

12 Jun 2005

Medical News

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Novel and more effective way of testing which gene mutations cause cancer

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Half of 580 women diagnosed with breast cancer in one study experienced lymphedema

Researchers discover how microRNA are involved in the development of heart muscle

Bio-engineered skin provides clues to melanoma development

Genetic variations predispose Mexican Americans to insulin resistance

Link between PKC enzyme and kidney disease in diabetes confirmed

Dendritic cell vaccination can dramatically speed up the immunization process

Venom of marine cone snails may provide an improved treatment for neuropathic pain associated with diabetes

Over-the-counter painkillers more likely to cause heart attacks than banned drug Vioxx

West Nile virus vaccine may be ready by the end of the year

FDA approves whooping cough vaccine for adults

Mad cow disease found in animal in the U.S.

No need to rush to take epilepsy drugs

Crystal Meth Summit in Canada wants drug re-classified

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News